Methods to detect tumors using 20P1F12/TMPRSS2 expression
    1.
    发明授权
    Methods to detect tumors using 20P1F12/TMPRSS2 expression 有权
    使用20P1F12 / TMPRSS2表达检测肿瘤的方法

    公开(公告)号:US07981624B2

    公开(公告)日:2011-07-19

    申请号:US12389293

    申请日:2009-02-19

    IPC分类号: G01N33/53

    摘要: Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-regulated, cell membrane associated and secreted serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding sequence of the 20P1F12/TMPRSS2 gene (also designated 20P1F12-GTC1 herein) is provided (FIG. 1). Among the compositions provided are antibodies that bind to 20P1F12/TMPRSS2 proteins and polypeptide fragments thereof, including antibodies labeled with a detectable marker or toxin or therapeutic composition. The invention also provides prognostic and diagnostic methods of examining a biological sample for evidence of disregulated cellular growth by comparing the status of 20P1F12/TMPRSS2 in the biological sample to the status of 20P1F12/TMPRSS2 in a corresponding normal sample, wherein alterations in the status of 20P1F12/TMPRSS2 in the biological sample are associated with disregulated cellular growth. The invention further provides various therapeutic compositions and strategies for treating prostate cancer, including particularly, 20P1F12/TMPRSS2 polypeptide and anti-20P1F12/TMPRSS2 antibody therapy methods and compositions, cancer vaccines, and small molecule therapy.

    摘要翻译: 描述了衍生自或基于称为20P1F12 / TMPRSS2的新型前列腺特异性,雄激素调节的细胞膜相关和分泌的丝氨酸蛋白酶的前列腺和结肠癌的诊断和治疗的组合物。 提供了包含20P1F12 / TMPRSS2基因(本文中也称为20P1F12-GTC1)的整个编码序列的全长cDNA(图1)。 所提供的组合物是结合20P1F12 / TMPRSS2蛋白和其多肽片段的抗体,包括用可检测标记或毒素或治疗组合物标记的抗体。 本发明还提供了通过将生物样品中20P1F12 / TMPRSS2的状态与对应的正常样品中的20P1F12 / TMPRSS2的状态进行比较来检查生物样品以检测细胞生长失调的证据的预后和诊断方法,其中, 生物样品中的20P1F12 / TMPRSS2与细胞生长失调有关。 本发明还提供了治疗前列腺癌的各种治疗组合物和策略,特别包括20P1F12 / TMPRSS2多肽和抗-20P1F12 / TMPRSS2抗体治疗方法和组合物,癌症疫苗和小分子治疗。

    Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
    2.
    发明授权
    Tumor antigen useful in diagnosis and therapy of prostate and colon cancer 失效
    肿瘤抗原可用于诊断和治疗前列腺和结肠癌

    公开(公告)号:US07037667B1

    公开(公告)日:2006-05-02

    申请号:US09615285

    申请日:2000-07-12

    IPC分类号: G01N33/574 G01N33/48 C12Q1/68

    摘要: Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-related, cell membrane associated and secreted serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding sequence of the 20P1F12/TMPRSS2 gene (also designated 20P1F12-GTC1 herein) is provided (FIG. 1). Among the compositions provided are antibodies that bind to 20P1F12/TMPRSS2 proteins and polypeptide fragments thereof, including antibodies labeled with a detectable marker or toxin or therapeutic composition. The invention also provides prognostic and diagnostic methods of examining a biological sample for evidence of disregulated cellular growth by comparing the status of 20P1F12/TMPRSS2 in the biological sample to the status of 20P1F12/TMPRSS2 in a corresponding normal sample, wherein alterations in the status of 20P1F12/TMPRSS2 in the biological sample are associated with disregulated cellular growth. The invention further provides various therapeutic compositions and strategies for treating prostate cancer, including particularly, 20P1F12/TMPRSS2 polypeptide and anti-20P1F12/TMPRSS2 antibody therapy methods and compositions, cancer vaccines, and small molecule therapy.

    摘要翻译: 描述了源自或基于名为20P1F12 / TMPRSS2的新型前列腺特异性雄激素相关的细胞膜相关和分泌的丝氨酸蛋白酶的前列腺和结肠癌的诊断和治疗的组合物。 提供了包含20P1F12 / TMPRSS2基因(本文中也称为20P1F12-GTC1)的整个编码序列的全长cDNA(图1)。 所提供的组合物是结合20P1F12 / TMPRSS2蛋白和其多肽片段的抗体,包括用可检测标记或毒素或治疗组合物标记的抗体。 本发明还提供了通过将生物样品中20P1F12 / TMPRSS2的状态与对应的正常样品中的20P1F12 / TMPRSS2的状态进行比较来检查生物样品以检测细胞生长失调的证据的预后和诊断方法,其中, 生物样品中的20P1F12 / TMPRSS2与细胞生长失调有关。 本发明还提供了治疗前列腺癌的各种治疗组合物和策略,特别包括20P1F12 / TMPRSS2多肽和抗-20P1F12 / TMPRSS2抗体治疗方法和组合物,癌症疫苗和小分子治疗。

    METHODS TO DETECT TUMORS USING 20P1F12/TMPRSS2 EXPRESSION
    3.
    发明申请
    METHODS TO DETECT TUMORS USING 20P1F12/TMPRSS2 EXPRESSION 有权
    使用20P1F12 / TMPRSS2表达检测肿瘤的方法

    公开(公告)号:US20090226921A1

    公开(公告)日:2009-09-10

    申请号:US12389293

    申请日:2009-02-19

    IPC分类号: C12Q1/68

    摘要: Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-regulated, cell membrane associated and secreted serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding sequence of the 20P1F12/TMPRSS2 gene (also designated 20P1F12-GTC1 herein) is provided (FIG. 1). Among the compositions provided are antibodies that bind to 20P1F12/TMPRSS2 proteins and polypeptide fragments thereof, including antibodies labeled with a detectable marker or toxin or therapeutic composition. The invention also provides prognostic and diagnostic methods of examining a biological sample for evidence of disregulated cellular growth by comparing the status of 20P1F12/TMPRSS2 in the biological sample to the status of 20P1F12/TMPRSS2 in a corresponding normal sample, wherein alterations in the status of 20P1F12/TMPRSS2 in the biological sample are associated with disregulated cellular growth. The invention further provides various therapeutic compositions and strategies for treating prostate cancer, including particularly, 20P1F12/TMPRSS2 polypeptide and anti-20P1F12/TMPRSS2 antibody therapy methods and compositions, cancer vaccines, and small molecule therapy.

    摘要翻译: 描述了衍生自或基于称为20P1F12 / TMPRSS2的新型前列腺特异性,雄激素调节的细胞膜相关和分泌的丝氨酸蛋白酶的前列腺和结肠癌的诊断和治疗的组合物。 提供了包含20P1F12 / TMPRSS2基因(本文中也称为20P1F12-GTC1)的整个编码序列的全长cDNA(图1)。 所提供的组合物是结合20P1F12 / TMPRSS2蛋白和其多肽片段的抗体,包括用可检测标记或毒素或治疗组合物标记的抗体。 本发明还提供了通过将生物样品中20P1F12 / TMPRSS2的状态与对应的正常样品中的20P1F12 / TMPRSS2的状态进行比较来检查生物样品以检测细胞生长失调的证据的预后和诊断方法,其中, 生物样品中的20P1F12 / TMPRSS2与细胞生长失调有关。 本发明还提供了治疗前列腺癌的各种治疗组合物和策略,特别包括20P1F12 / TMPRSS2多肽和抗-20P1F12 / TMPRSS2抗体治疗方法和组合物,癌症疫苗和小分子治疗。

    Serpentine transmembrane antigens expressed in human cancers and uses thereof
    4.
    发明授权
    Serpentine transmembrane antigens expressed in human cancers and uses thereof 有权
    在人类癌症中表达的蛇纹石跨膜抗原及其用途

    公开(公告)号:US07166714B2

    公开(公告)日:2007-01-23

    申请号:US10750262

    申请日:2003-12-31

    IPC分类号: C07H21/02 C07H21/04 C12N15/00

    摘要: Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” (Six Transmembrane Epithelial Antigens of the Prostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a “serpentine” manner into three extracellular and two intracellular loops. STEAP-1 protein expression is maintained at high levels across various stages of prostate cancer. Moreover, STEAP-1 is highly over-expressed in certain other human cancers.

    摘要翻译: 描述了一种新型的细胞表面蛇纹石跨膜抗原家族。 该家族中的两种蛋白质仅在或主要地在前列腺中表达,并且在前列腺癌中,因此该家族的成员被称为“STEAP”(前列腺的六个跨膜上皮原体)。 本文描述和表征了四种特定的人STEAP。 人类STEAP在其中表现出高度的结构保守性,但与任何已知的人类蛋白质没有显着的结构同源性。 STEAP家族的原型成员STEAP-1似乎是主要在正常人体组织中的前列腺细胞中表达的IIIa型膜蛋白。 在结构上,STEAP-1是一种339个氨基酸的蛋白质,其特征在于六个跨膜结构域和细胞内N-和C-末端的分子拓扑结构,表明它以“蛇纹石”的方式折叠成三个胞外和两个细胞内环。 STEAP-1蛋白表达在前列腺癌的各个阶段保持在高水平。 此外,STEAP-1在某些其他人类癌症中高度过度表达。

    Louvered chip screener
    5.
    发明授权
    Louvered chip screener 失效
    百叶切片机

    公开(公告)号:US4802591A

    公开(公告)日:1989-02-07

    申请号:US167690

    申请日:1988-03-14

    摘要: A machine and method for separating chip-like particles according to thickness which provides low blinding and high efficiency at high throughput in sustained operation. The machine has a sloping deck mounting a series of spaced flexible louvers or slats which extend parallel to the direction of chip flow down the deck. The slats are canted transversely to the direction of flow, and present unobstructed full length slot-like chip openings between them. The deck is driven with a horizontal gyratory motion such that during the upstream half of each cycle of movement, each slot moves toward chips on the adjacent slat which slopes toward it, and moves away from such chips during the downstream half of the cycle. The path of screening movement is uniform over the entire deck, that is, the motion of the lower or discharge end of the deck matches that of the upper or feed end. Adjacent slats are supported at alternate or staggered positions along their length so that they can deflect slightly relative to one other along their entire length. Ball cleaners are directed to impact on the slats in the transverse direction to deflect them and thereby dislodge chips stuck between the slats.

    摘要翻译: 根据厚度分离芯片状颗粒的机器和方法,其在持续操作中以高产量提供低盲目性和高效率。 该机器具有倾斜的甲板,其安装了一系列间隔开的柔性百叶窗或板条,其平行于芯片沿着甲板流动的方向延伸。 板条横向于流动方向倾斜,并且在它们之间呈现无阻碍的全长槽状切屑开口。 甲板由水平回转运动驱动,使得在每个运动循环的上游一半期间,每个槽向靠近其倾斜的相邻板条上的切屑移动,并在该循环的下半部分期间离开这种切屑。 整个甲板上的筛选运动的路径是均匀的,也就是说,甲板的下部或排放端的运动与上部或进料端的运动相匹配。 相邻的板条沿着它们的长度被支撑在交替或交错的位置处,使得它们可以沿其整个长度相对于彼此稍微偏转。 球形清洁剂被引导以在横向上对板条的冲击以使其偏转,从而移除卡在板条之间的碎屑。

    Wheel
    6.
    发明授权
    Wheel 失效

    公开(公告)号:US3977728A

    公开(公告)日:1976-08-31

    申请号:US537359

    申请日:1974-12-30

    摘要: A wheel comprising a plurality of wheel plies, each wheel ply including concentric inner and outer hoops and a plurality of circumferentially spaced spoke loops therebetween, wherein each of the spoke loops is entrapped within the hoops. In one embodiment the wheel comprises a laminate of alternating wheel plies and intermediate plies bonded together. A spoked frame comprising one or more of the wheels is provided, the frame including fairing means to substantially envelope the spokes and retain the individual wheels in their proper spacial relationship.

    摘要翻译: 包括多个轮子层的车轮,每个车轮帘布层包括同心的内圈和外圈以及在其间的多个周向间隔的轮辐环,其中每个轮辐环被夹在箍中。 在一个实施例中,车轮包括交替的轮子层和粘结在一起的中间帘布层的叠层。 提供了包括一个或多个轮的发射框架,框架包括整流装置,以基本上包围辐条并将各个车轮保持在适当的空间关系。

    Self-locking hold-down clamp
    8.
    发明授权
    Self-locking hold-down clamp 失效
    自锁式压紧夹

    公开(公告)号:US5074012A

    公开(公告)日:1991-12-24

    申请号:US701788

    申请日:1991-05-17

    IPC分类号: B07B1/46 B07B1/48 F16B39/282

    摘要: A self-locking clamp has a handle which locks to a non-rotating member if the handle starts to turn while in clamping use. The clamp has a retractable collar which is splined to the handle and is biased toward locking engagement with a sleeve that in turn seats against the member to be clamped. The collar can be held retracted from the sleeve for tightening and loosening the clamp.

    摘要翻译: 如果手柄在夹紧使用时开始转动,则自锁夹具具有锁定到非旋转构件的手柄。 夹具具有可伸缩的套环,其可以花键连接到手柄并被偏压以与套筒锁定接合,该套筒又抵靠待夹紧的构件。 套环可以从套筒中缩回以收紧和松开夹具。

    Projectile shield
    10.
    发明授权
    Projectile shield 失效
    射弹盾

    公开(公告)号:US5437538A

    公开(公告)日:1995-08-01

    申请号:US144098

    申请日:1993-10-28

    摘要: An improved blade containment structure including a projectile shield having a braided ballistic fabric is disclosed. The braided fabric includes ballistic strands arranged in a preferred orientation and is effective for increasing the ability of the fabric to contain projectiles and absorb energy therefrom. The braided ballistic fabric provides substantial improvement in performance over conventional woven ballistic fabrics.

    摘要翻译: 公开了一种改进的叶片容纳结构,其包括具有编织弹道织物的抛射屏蔽。 编织物包括以优选取向布置的防弹绳,并且有效地增加织物包含弹丸并从中吸收能量的能力。 编织弹道织物在性能上比传统的编织弹道织物提供了显着的改进。